Results 321 to 330 of about 218,068 (352)
Some of the next articles are maybe not open access.
Acute Lymphoblastic Leukemia of Childhood
Hematology/Oncology Clinics of North America, 1987Over the last 20 years, the rate of long-term disease-free survival of childhood acute lymphoblastic leukemia increased from less than 1 to 60 per cent. Strategies for disease control include (1) intensive multiagent induction to rapidly decrease the tumor burden and minimize the chance of emergence of a resistant population of cells, (2) restoration ...
openaire +3 more sources
Acute Lymphoblastic Leukemia in Adults
Annals of Internal Medicine, 1984Excerpt Considerable progress has been made during the last 20 years in the treatment of children with acute lymphoblastic leukemia.
openaire +3 more sources
Acute lymphoblastic leukemia in children
Current Opinion in Oncology, 2000As the overall long-term event-free survival rate in children with acute lymphoblastic leukemia approaches 80%, emphasis is being placed on risk-directed therapy so that patients are neither overtreated nor undertreated. It has become apparent that a risk assignment system based on primary genetic abnormalities is inadequate by itself.
openaire +3 more sources
Acute lymphoblastic leukemia in infancy
Pediatric Blood & Cancer, 2007Infant ALL is uncommon, biologically distinctive from the disease in older children, and associated with a relatively poor prognosis. Adverse prognostic factors include the presence of an MLL gene rearrangement (observed in up to 80% of infants with ALL), younger age at diagnosis, high presenting leukocyte counts, and slow early response to therapy ...
openaire +3 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Acute Lymphoblastic Leukemia: Background
2003Acute lymphoblastic leukemia is a fascinating disease for the cytogeneticist, as so many cases have a clone detectable by cytogenetics or FISH, and because identifying the abnormalities provides such useful information to the clinician. However, it is also a frustrating disease, as it has technical challenges such as a marked tendency for the sample to
openaire +2 more sources
Relapsed acute lymphoblastic leukemia
American Journal of Ophthalmology, 2021Judy L. Chen +2 more
openaire +3 more sources

